Lastly, an antagonist of serum and glucocorticoid-regulated kinase 1 (SGK1), an androgen-regulated target gene, was found to block AR-mediated LNCaP cell growth [130], suggesting that the inhibition of GR-related pathways may have a therapeutic benefit in PCa [131,160]. Here, AR is linked to posterior cortical atrophy.